International Stem Cell Corp. (ISCO) Banks On Non-Embryonic Histocompatible Stem Cells
Along with the growing development of stem cell technology as a tool for both research and therapeutics, stem cell banking…
Blog
Cytomedix, Inc. (CMXI) and Possible Partner Extend Exclusivity and Enter Distribution Negotiations
Cytomedix, a regenerative therapies company focused on commercializing and developing innovative platelet and adult stem cell technologies for wound and…
USA Recycling Industries, Inc. (USRI) Grows Through Company Owned and Partnership Recycling Centers
USA Recycling Industries is a recyclable waste collection and disposal company serving commercial and industrial customers throughout North America, operating…
Tegal Corp. (TGAL) Appoints James Karis as Co-CEO of the Company
Tegal has been in business for 40 years, with a current focus on emerging technologies in the healthcare sector. The…
Comstock Mining Inc. (LODE) Finishes Heap Leach Facility and Pond, Preps Lucerne West Mine for Production
Comstock Mining has amassed a considerable footprint of contiguous gold and silver acreage in Nevada's legendary Comstock District and was…
Skinny Nutritional Corp. (SKNY) Receives $15,000,000 Financing to Accelerate Growth Initiatives
Skinny Nutritional, the maker of Skinny Water® and a leader in the zero-calorie enhanced water category, announced this morning that…
Anthera Pharmaceuticals, Inc. (ANTH) Video Chart for Monday, June 2, 2012
A look at ANTH's 15-minute charts, combined with the daily charts, shows that the stock could be aligning for a…
Vidable, Inc. (VIBE) Spammed Aggressively over Weekend
We have observed an influx of emails spamming Vidable from various free email accounts over the weekend. Investors should be…
Seeking Alpha Article Features International Stem Cell Corp. (ISCO), Touts Stem Cell Technology’s Bright Future
In an article published earlier today featuring key players in the stem cell industry, International Stem Cell Corp. was labeled…
Ohr Pharmaceutical, Inc. (OHRP) Announces $2.91M Financing through Exercised Series H Warrants
Ohr Pharmaceutical today announced that its existing shareholders have exercised 5,299,022 Series H warrants at $0.55 per warrant, resulting in…